FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bruno Lacarelle

Research Profile

Chemicals & Drugs

Anatomy

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Alexandre Evrard; Bruno Lacarelle; Joseph Ciccolini
Severe or lethal toxicities with nucleosidic analogs: time for action.
Roberto Crocchiolo; Raynier Devillier; Jean El-Cheikh; Sabine Fürst; Angela Granata; Samia Harbi; Bruno Lacarelle; Stevan Legall; Claire Oudin; Gilles Paintaud; David Ternant; Luca Castagna; Joseph Ciccolini; Didier Blaise
Successful treatment of post-transplant Epstein-Barr virus-related meningoencephalitis by intravenous rituximab monotherapy.
Mireille Bartoli; C Berny; B Capolaghi; Vincent Danel; Arnaud Delahaye; G Desch; Jérôme Guitton; Bruno Lacarelle; Frédéric Lapostolle; Daniel Mathieu; Bruno Mégarbane; Patrick Nisse; Anton Szymanowicz
[Recommendations for the prescription, implementation and interpretation of medical examinations in biology in the context of severe poisoning].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bruno Lacarelle (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alexandre Evrard; Bruno Lacarelle; Joseph Ciccolini
Severe or lethal toxicities with nucleosidic analogs: time for action.
Pharmacogenomics 2013;14(3):227-30.
2012: Roberto Crocchiolo; Raynier Devillier; Jean El-Cheikh; Sabine Fürst; Angela Granata; Samia Harbi; Bruno Lacarelle; Stevan Legall; Claire Oudin; Gilles Paintaud; David Ternant; Luca Castagna; Joseph Ciccolini; Didier Blaise
Successful treatment of post-transplant Epstein-Barr virus-related meningoencephalitis by intravenous rituximab monotherapy.
Leukemia & lymphoma 2012;53(10):2063-5.
2012: Mireille Bartoli; C Berny; B Capolaghi; Vincent Danel; Arnaud Delahaye; G Desch; Jérôme Guitton; Bruno Lacarelle; Frédéric Lapostolle; Daniel Mathieu; Bruno Mégarbane; Patrick Nisse; Anton Szymanowicz
[Recommendations for the prescription, implementation and interpretation of medical examinations in biology in the context of severe poisoning].
Annales de biologie clinique 2012;70(4):431-50.
2012: Joseph Ciccolini; Alexandre Evrard; Athanassios Iliadis; Bruno Lacarelle; Lithaty M'Batchi; Cédric Mercier; L'Houcine Ouafik; Bertrand Pourroy; Arnaud Verschuur; Nicolas Andre
CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations.
Pharmacogenomics 2012;13(4):393-7.
2012: Laetitia Dahan; Alexandre Evrard; Athanassios Iliadis; Bruno Lacarelle; Litaty Mbatchi; Cedric Mercier; Emmanuelle Norguet; L'Houcine Ouafik; Pauline Ries; Joseph Ciccolini; Jack Tibbitts; Jean-Francois Seitz
Sudden death related to toxicity in a patient on capecitabine and irinotecan plus bevacizumab intake: pharmacogenetic implications.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(4):e41-4.
2012: Sophie Perrin; Isabelle Poizot-Martin; Jacques Reynes; Andrée Robaglia-Schlupp; Caroline Solas; Charlotte Stretti; Corine Nicolino-Brunet Catherine Tamalet; Pierre Cau; Jonathan Cremer; Pierre Dellamonica; Olivia Faucher; Elise Kaspi; Bruno Lacarelle; Nicolas Lévy; Joëlle Micallef; Patrice Roll
HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study.
PloS one 2012;7(12):e53035.
2012: Christian Woloch; Bruno Lacarelle; Hafedh Marouani; Guido Bocci; Joseph Ciccolini; Romano Danesi; Antonello Di Paolo; Athanassios Iliadis
Population pharmacokinetic analysis of 5-FU and 5-FDHU in colorectal cancer patients: search for biomarkers associated with gastro-intestinal toxicity.
Current topics in medicinal chemistry 2012;12(15):1713-9.
2012: Stephan Benay; Joseph Ciccolini; Raphaelle Fanciullino; Athanassios Iliadis; Cedric Mercier; Bruno Lacarelle
100% human monoclonal antibodies in oncology: hype or breakthrough?
Current topics in medicinal chemistry 2012;12(15):1643-8.
2011: Romain Guilhaumou; Bruno Lacarelle; Sylvie Quaranta; Angelique Rome; Nicolas Simon; Caroline Solas; Véronique Bourgarel-Rey; Nicolas Andre
Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity.
Cancer chemotherapy and pharmacology 2011;68(6):1633-8.
2011: Romain Guilhaumou; Bruno Lacarelle; Sylvie Quaranta; Nicolas Simon; Nicolas Andre; Arnauld Verschuur; Caroline Solas
Population pharmacokinetics and pharmacogenetics of vincristine in paediatric patients treated for solid tumour diseases.
Cancer chemotherapy and pharmacology 2011;68(5):1191-8.
2011: Pierre-Yves Cordier; Bruno Lacarelle; Cédric Mercier; André NAU; Manuela Oliver; Joseph Ciccolini; Eric Peytel
5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases.
Cancer chemotherapy and pharmacology 2011;68(3):823-6.
2011: Chen Guang Yang; Joseph Ciccolini; Aurore Blesius; Laetitia Dahan; Danielle Bagarry-Liegey; Caroline Brunet; Arthur Varoquaux; Nicolas Frances; Hafedh Marouani; Antoine Giovanni; Rose-Marie Ferri-Dessens; Mohamed Chefrour; Roger Favre; Florence Duffaud; Jean-François Seitz; Michel Zanaret; Bruno Lacarelle; Cédric Mercier
DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity.
Cancer chemotherapy and pharmacology 2011;67(1):49-56.
2010: Joseph Ciccolini; Eva Gross; Laetitia Dahan; Bruno Lacarelle; Cédric Mercier
Routine dihydropyrimidine dehydrogenase testing for anticipating 5-fluorouracil-related severe toxicities: hype or hope?
Clinical colorectal cancer 2010;9(4):224-8.
2010: Romain Guilhaumou; Caroline Solas; Angelique Rome; Madeleine Giocanti; Nicolas Andre; Bruno Lacarelle
Validation of an electrospray ionization LC/MS/MS method for quantitative analysis of vincristine in human plasma samples.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2010;878(3-4):423-7.
2009: Sylvie Quaranta; Christian Woloch; Alexandre Paccou; Madeleine Giocanti; Caroline Solas; Bruno Lacarelle
Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
Therapeutic drug monitoring 2009;31(6):695-702.
2009: Amélie Ménard; Caroline Solas; Saadia Mokthari; Sylvie Bregigeon; Marie-Pierre Drogoul; Catherine Tamalet; Bruno Lacarelle; Isabelle Poizot Martin
Etravirine-raltegravir, a marked interaction in HIV-1-infected patients: about four cases.
AIDS (London, England) 2009;23(7):869-71.
2009: Emilie Milano-Bausset; jean gaudart; Angelique Rome; Carole Coze; Jean-Claude Gentet; Laetitia Padovani; Bruno Lacarelle; Nicolas Andre
Retrospective comparison of neutropenia in children with Ewing sarcoma treated with chemotherapy and granulocyte colony-stimulating factor (G-CSF) or pegylated G-CSF.
Clinical therapeutics 2009;31 Pt 2():2388-95.
2008: Caroline Solas; Marie-Claude Gagnieu; Isabelle Ravaux; Marie-Pierre Drogoul; Alain Lafeuillade; Saadia Mokhtari; Bruno Lacarelle; Nicolas Simon
Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients.
Therapeutic drug monitoring 2008;30(6):670-3.
2008: Caroline Solas; Philippe Colson; Isabelle Ravaux; Isabelle Poizot-Martin; Jacques Moreau; Bruno Lacarelle; Catherine Tamalet
The genotypic inhibitory quotient: a predictive factor of atazanavir response in HIV-1-infected treatment-experienced patients.
Journal of acquired immune deficiency syndromes (1999) 2008;48(2):177-80.
2007: Caroline Solas; Nicolas Simon; Marie-Pierre Drogoul; Sylvie Quaranta; Véronique Frixon-Marin; Véronique Bourgarel-Rey; Corinne Brunet; Jean-Albert Gastaut; Alain Durand; Bruno Lacarelle; Isabelle Poizot-Martin
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients.
British journal of clinical pharmacology 2007;64(3):353-62.
2007: M-A Estève; B Devictor-Pierre; G Galy; Nicolas Andre; Carole Coze; Bruno Lacarelle; Jean Louis Bernard; Suzanne Monjanel-Mouterde
Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation.
European journal of clinical pharmacology 2007;63(1):39-42.
2006: Sylvie Quaranta; Dany Chevalier; Delphine Allorge; Jean-Marc Lo-Guidice; Florence Migot-Nabias; Abderaouf Kenani; Michel Imbenotte; Franck Broly; Bruno Lacarelle; Michel Lhermitte
Ethnic differences in the distribution of CYP3A5 gene polymorphisms.
Xenobiotica; the fate of foreign compounds in biological systems 2006;36(12):1191-200.
2006: Joseph Ciccolini; Cedric Mercier; Alexandre Evrard; Laetitia Dahan; Jean-Christophe Boyer; Florence Duffaud; Karine Richard; Carmelo Blanquicett; Gérard Milano; Aurore Blesius; Alain Durand; Jean-François Seitz; Roger Favre; Bruno Lacarelle
A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapy.
Therapeutic drug monitoring 2006;28(5):678-85.
2006: Rémy Largillier; Marie-Christine Etienne-Grimaldi; Jean-Louis Formento; Joseph Ciccolini; Jean-François Nebbia; Aurélie Ginot; Mireille Francoual; Nicole Renée; Jean-Marc Ferrero; Cyril Foa; Moïse Namer; Bruno Lacarelle; Gérard Milano
Pharmacogenetics of capecitabine in advanced breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5496-502.
2006: Sébastien Salas; Cedric Mercier; Joseph Ciccolini; Bertrand Pourroy; Raphaelle Fanciullino; Brigitte Tranchand; Suzanne Monjanel-Mouterde; Marjorie Baciuchka-Palmaro; Charlotte Dupuis; Chenguang Yang; Medhi Balti; Bruno Lacarelle; Florence Duffaud; Alain Durand; Roger Favre
Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma.
Therapeutic drug monitoring 2006;28(4):532-9.
2006: Joseph Ciccolini; Cedric Mercier; Laetitia Dahan; Alexandre Evrard; Jean-Christophe Boyer; Karine Richard; Jean-Philippe Dales; Alain Durand; Gérard Milano; Jean-François Seitz; Bruno Lacarelle
Toxic death-case after capecitabine + oxaliplatin (XELOX) administration: probable implication of dihydropyrimidine deshydrogenase deficiency.
Cancer chemotherapy and pharmacology 2006;58(2):272-5.
2006: Sylvie Quaranta; Dany Chevalier; Véronique Bourgarel-Rey; Delphine Allorge; Caroline Solas; Jean-Marc Lo-Guidice; Emmanuelle Sampol-Manos; Henri Vacher-Coponat; Valérie Moal; Franck Broly; Michel Lhermitte; Bruno Lacarelle
Identification by single-strand conformational polymorphism analysis of known and new mutations of the CYP3A5 gene in a French population.
Toxicology letters 2006;164(2):177-84.
2006: Emmanuelle Sampol-Manos; M Leone; D Karouia; V Savelli; E Ragni; D Rossi; A Durand; Bruno Lacarelle; Claude Martin
Prophylaxis with ciprofloxacin for open prostatectomy: comparison of tissue penetration with two oral doses.
Journal of chemotherapy (Florence, Italy) 2006;18(2):225-6.
2006: Cedric Mercier; Joseph Ciccolini; Bertrand Pourroy; Raphaelle Fanciullino; Florence Duffaud; Laurence Digue; Brigitte Tranchand; Suzanne Monjanel-Mouterde; Pierre Guillet; Adriana Nicoara; Marjorie Baciuchka; Danielle Bagarry-Liegey; Bruno Lacarelle; Alex Noble; Alain Durand; Roger Favre
Dose individualization of carboplatin after a 120-hour infusion schedule: higher dose intensity but fewer toxicities.
Therapeutic drug monitoring 2006;28(2):212-8.
2006: Nicolas Simon; Bertrand Dussol; Emmanuelle Sampol; Raj Purgus; Philippe Brunet; Bruno Lacarelle; Yvon Berland; Bernard Bruguerolle; Saïk Urien
Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients.
Clinical pharmacokinetics 2006;45(5):493-501.
2005: Frédérique Fallone; Pierre-Henri Villard; Laetitia Decome; Eric Sérée; Michel de Méo; Christine Chacon; Alain Durand; Yves Barra; Bruno Lacarelle
PPARalpha activation potentiates AhR-induced CYP1A1 expression.
Toxicology 2005;216(2-3):122-8.
2005: Bertrand Pourroy; C Botta; Caroline Solas; Bruno Lacarelle; Diane Braguer
Seventy-two-hour stability of Taxol in 5% dextrose or 0.9% sodium chloride in Viaflo, Freeflex, Ecoflac and Macoflex N non-PVC bags.
Journal of clinical pharmacy and therapeutics 2005;30(5):455-8.
2004: Eric Sérée; Pierre-Henri Villard; Jean-Marc Pascussi; Thierry Pineau; P Maurel; Quock Binh Nguyen; Frédérique Fallone; Pierre-Marie Martin; Serge Champion; Bruno Lacarelle; J-F Savouret; Yves Barra
Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites.
Gastroenterology 2004;127(5):1436-45.
2004: Frédérique Fallone; Pierre-Henri Villard; Eric Sérée; Odile Rimet; Quock Binh Nguyen; Véronique Bourgarel-Rey; Francis Fouchier; Yves Barra; Alain Durand; Bruno Lacarelle
Retinoids repress Ah receptor CYP1A1 induction pathway through the SMRT corepressor.
Biochemical and biophysical research communications 2004;322(2):551-6.
2004: Joseph Ciccolini; Cedric Mercier; MF Blachon; Roger Favre; Alain Durand; Bruno Lacarelle
A simple and rapid high-performance liquid chromatographic (HPLC) method for 5-fluorouracil (5-FU) assay in plasma and possible detection of patients with impaired dihydropyrimidine dehydrogenase (DPD) activity.
Journal of clinical pharmacy and therapeutics 2004;29(4):307-15.
2004: Caroline Solas; Isabelle Poizot-Martin; Marie-Pierre Drogoul; Isabelle Ravaux; Catherine Dhiver; Alain Lafeuillade; Thierry Allegre; Malika Mokhtari; Jacques Moreau; Gérard Lepeu; Nathalie Petit; Alain Durand; Bruno Lacarelle
Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitor.
British journal of clinical pharmacology 2004;57(4):436-40.
2004: Hugues Chevassus; Isabelle Mourand; Nathalie Molinier; Bruno Lacarelle; Jean-Frédéric Brun; Pierre Petit
Assessment of single-dose benzodiazepines on insulin secretion, insulin sensitivity and glucose effectiveness in healthy volunteers: a double-blind, placebo-controlled, randomized cross-over trial [ISRCTN08745124].
BMC clinical pharmacology 2004;4():3.
2004: Marc Leone; Jacques Albanèse; Emmanuelle Sampol-Manos; Nicolas Simon; Bruno Lacarelle; Bernard Bruguerolle; Claude Martin
Moxifloxacin penetration in bronchial secretions of mechanically ventilated patients with pneumonia.
Antimicrobial agents and chemotherapy 2004;48(2):638-40.
2003: Nicolas Simon; Emmanuelle Sampol; Jacques Albanese; Claude Martin; Pierre Arvis; Saïk Urien; Bruno Lacarelle; Bernard Bruguerolle
Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia.
Clinical pharmacology and therapeutics 2003;74(4):353-63.
2003: Alain Lafeuillade; Caroline Solas; Stéphane Chadapaud; Gilles Hittinger; Cécile Poggi; Bruno Lacarelle
HIV-1 RNA levels, resistance, and drug diffusion in semen versus blood in patients receiving a lopinavir-containing regimen.
Journal of acquired immune deficiency syndromes (1999) 2003;32(4):462-4.
2003: Caroline Solas; Alain Lafeuillade; Philippe Halfon; Stéphane Chadapaud; Gilles Hittinger; Bruno Lacarelle
Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients.
Antimicrobial agents and chemotherapy 2003;47(1):238-43.
2002: Caroline Solas; N Petit; M Orticoni; Alain Durand; Jean-Albert Gastaut; Bruno Lacarelle
Experience of a combination including indinavir 400 mg plus ritonavir 200 mg twice daily in HIV-infected patients: pharmacokinetic data.
Pathologie-biologie 2002;50(9):565-7.
2002: Marc Leone; Emmanuelle Sampol-Manos; Dominique Santelli; Stéphanie Grabowski; Bernard Alliez; Alain Durand; Bruno Lacarelle; Claude Martin
Brain tissue penetration of ciprofloxacin following a single intravenous dose.
The Journal of antimicrobial chemotherapy 2002;50(4):607-9.
2002: Quoc-Binh N'Guyen; Frédérique Fallone; Eric Seree; Frederic Fina; Pierre-Henri Villard; Nolwen Guigal; Michel De Meo; Bruno Lacarelle; Pierre-Marie Martin; Yves Barra
Serum increases CYP1A1 induction by 3-methylcholanthrene.
Biochemical and biophysical research communications 2002;297(2):249-54.
2002: Stéphanie Basso; Caroline Solas; Anne-Marie Quinson; Isabelle Ravaux; Isabelle Poizot-Martin; J Bacconier; Alain Durand; Bruno Lacarelle
Pharmacokinetic interaction between lopinavir/r and amprenavir in salvage therapy.
Journal of acquired immune deficiency syndromes (1999) 2002;31(1):115-7.
2002: Caroline Solas; Stéphanie Basso; Isabelle Poizot-Martin; Isabelle Ravaux; Hervé Gallais; Jean-Albert Gastaut; Alain Durand; Bruno Lacarelle
High indinavir Cmin is associated with higher toxicity in patients on indinavir-ritonavir 800/100 mg twice-daily regimen.
Journal of acquired immune deficiency syndromes (1999) 2002;29(4):374-7.
2002: Pierre-Henri Villard; Emmanuelle Sampol; Jean L Elkaim; Franck Puyoou; Dominique Casanova; Eric Sérée; Alain Durand; Bruno Lacarelle
Increase of CYP1B1 transcription in human keratinocytes and HaCaT cells after UV-B exposure.
Toxicology and applied pharmacology 2002;178(3):137-43.
2002: Alain Lafeuillade; Caroline Solas; Philippe Halfon; Stéphane Chadapaud; Gilles Hittinger; Bruno Lacarelle
Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations.
HIV clinical trials 2002;3(1):27-35.
2001: S Duran; Caroline Solas; Bruno Spire; Maria Patrizia Carrieri; Jean-Gabriel Fuzibet; D Costagliola; Bruno Lacarelle; Jean-Paul Moatti
'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study.
AIDS (London, England) 2001;15(8):1075-7.
2000: T D Nguyen; Pierre-Henri Villard; A Barlatier; A E Elsisi; Elisabeth Jouve; N M Duc; C Sauze; Alain Durand; Bruno Lacarelle
Panax vietnamensis protects mice against carbon tetrachloride-induced hepatotoxicity without any modification of CYP2E1 gene expression.
Planta medica 2000;66(8):714-9.
2000: C Dumon; Caroline Solas; Isabelle Thuret; Hervé Chambost; Bruno Lacarelle; G Michel; Alain Durand
Relationship between efficacy, tolerance, and plasma drug concentration of ritonavir in children with advanced HIV infection.
Therapeutic drug monitoring 2000;22(4):402-8.
2000: Emmanuelle Sampol; A Jacquet; M Viggiano; V Bernini; Jean-Claude Manelli; Bruno Lacarelle; Alain Durand
Plasma, urine and skin pharmacokinetics of cefepime in burns patients.
The Journal of antimicrobial chemotherapy 2000;46(2):315-7.
2000: Jacques Albanèse; Marc Léone; Bernard Bruguerolle; ML Ayem; Bruno Lacarelle; Claude Martin
Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit.
Antimicrobial agents and chemotherapy 2000;44(5):1356-8.
2000: Manon Gantenbein; L Attolini; Bernard Bruguerolle; Pierre-Henri Villard; Franck Puyoou; Alain Durand; Bruno Lacarelle; Jean Hardwigsen; Yves Patrice Le Treut
Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A.
Drug metabolism and disposition: the biological fate of chemicals 2000;28(4):383-5.
1999: T D Nguyen; Laurence Oliva; Pierre-Henri Villard; Franck Puyoou; C Sauze; Anne-Marie Montet; Bruno Lacarelle; Alain Durand; Jean-Claude Montet
CYP2E1 and CYP3A1/2 gene expression is not associated with the ursodeoxycholate effect on ethanol-induced lipoperoxidation.
Life sciences 1999;65(11):1103-13.
1998: Eric Sérée; Pierre-Henri Villard; Aniko Hevér; Nolwen Guigal; Franck Puyoou; B Charvet; H Point-Scomma; E Lechevalier; Bruno Lacarelle; Yves Barra
Modulation of MDR1 and CYP3A expression by dexamethasone: evidence for an inverse regulation in adrenals.
Biochemical and biophysical research communications 1998;252(2):392-5.
1998: Pierre-Henri Villard; Régine Herber; Eric Sérée; L Attolini; Jacques Magdalou; Bruno Lacarelle
Effect of cigarette smoke on UDP-glucuronosyltransferase activity and cytochrome P450 content in liver, lung and kidney microsomes in mice.
Pharmacology & toxicology 1998;82(2):74-9.
1998: Pierre-Henri Villard; Eric Seree; J L Re; Michel De Meo; Yves Barra; L Attolini; G Dumenil; Jacques Catalin; Alain Durand; Bruno Lacarelle
Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung: relation to single strand breaks of DNA.
Toxicology and applied pharmacology 1998;148(2):195-204.
1997: Emmanuelle Sampol; A Mirrione; Pierre-Henri Villard; Philippe Piccerelle; H Scoma; Philippe Berbis; Yves Barra; Alain Durand; Bruno Lacarelle
Evidence for a tissue-specific induction of cutaneous CYP2E1 by dexamethasone.
Biochemical and biophysical research communications 1997;235(3):557-61.
1997: M N Marchetti; Emmanuelle Sampol; Hot Bun; H Scoma; Bruno Lacarelle; Alain Durand
In vitro metabolism of three major isomers of retinoic acid in rats. Intersex and interstrain comparison.
Drug metabolism and disposition: the biological fate of chemicals 1997;25(5):637-46.
1997: C Garcia; P Philippot; Bruno Lacarelle; M Valli; B Rimé; Bernard Bruguerolle; Olivier Blin
Effects of lorazepam on film-induced differentiated emotions in healthy volunteers.
Fundamental & clinical pharmacology 1997;11(5):466-75.
1997: Pierre Guillet; S Monjanel; Adriana Nicoara; Florence Duffaud; Bruno Lacarelle; Danielle Bagarry-Liegey; Alain Durand; Jacques Catalin; Roger Favre
A Bayesian dosing method for carboplatin given by continuous infusion for 120 h.
Cancer chemotherapy and pharmacology 1997;40(2):143-9.
1996: L Attolini; Manon Gantenbein; Pierre-Henri Villard; Bruno Lacarelle; Jacques Catalin; Bernard Bruguerolle
Effects of different exposure times to tobacco smoke intoxication on carboxyhemoglobin and hepatic enzymate activities in mice.
Journal of pharmacological and toxicological methods 1996;35(4):211-5.
1996: E M Seree; Pierre-Henri Villard; J L Re; M De Meo; Bruno Lacarelle; L Attolini; G Dumenil; Jacques Catalin; Alain Durand; Yves Barra
High inducibility of mouse renal CYP2E1 gene by tobacco smoke and its possible effect on DNA single strand breaks.
Biochemical and biophysical research communications 1996;219(2):429-34.
1995: T Pignon; Bruno Lacarelle; Florence Duffaud; P Guillet; Jacques Catalin; A Durand; Roger Favre
Dosage adjustment of high-dose methotrexate using Bayesian estimation: a comparative study of two different concentrations at the end of 8-h infusions.
Therapeutic drug monitoring 1995;17(5):471-8.
1995: C Le Guellec; Bruno Lacarelle; Pierre-Henri Villard; H Point; Jacques Catalin; Alain Durand
Glucuronidation of propofol in microsomal fractions from various tissues and species including humans: effect of different drugs.
Anesthesia and analgesia 1995;81(4):855-61.
1995: Emmanuelle Sampol; Bruno Lacarelle; J F Rajaonarison; Jacques Catalin; Alain Durand
Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.
British journal of clinical pharmacology 1995;40(1):83-6.
1994: Pierre-Henri Villard; E Seree; Bruno Lacarelle; M C Therene-Fenoglio; Yves Barra; L Attolini; B Bruguerole; Alain Durand; Jacques Catalin
Effect of cigarette smoke on hepatic and pulmonary cytochromes P450 in mouse: evidence for CYP2E1 induction in lung.
Biochemical and biophysical research communications 1994;202(3):1731-7.
1994: T Gauthier; Bruno Lacarelle; F Marre; Pierre-Henri Villard; Jacques Catalin; Alain Durand
Predictive performance of two software packages (USC*PACK PC and Abbott PKS system) for the individualization of amikacin dosage in intensive care unit patients.
International journal of bio-medical computing 1994;36(1-2):131-4.
1994: Bruno Lacarelle; P Pisano; T Gauthier; Pierre-Henri Villard; F Guder; Jacques Catalin; Alain Durand
Abbott PKS system: a new version for applied pharmacokinetics including Bayesian estimation.
International journal of bio-medical computing 1994;36(1-2):127-30.
1994: F Coloma; Bruno Lacarelle; P Poitou; A Filleul; J Covo; Jacques Catalin
[Hepatic transport of mitoxantrone in relation to multiple resistance].
Bulletin du cancer 1994;81(5):425-30.
1994: Bruno Lacarelle; C Le Guellec; A Morel; J Albanese; M Alazia; M Ballereau; M Llurens; R Bruno; G Francois; A Durand
Monitoring of pefloxacin serum concentrations in intensive care unit patients: comparison of a new immunoassay with high-performance liquid chromatography.
Therapeutic drug monitoring 1994;16(2):209-13.
1994: T Pignon; Bruno Lacarelle; Florence Duffaud; P Guillet; Jacques Catalin; A Durand; S Monjanel; Roger Favre
Pharmacokinetics of high-dose methotrexate in adult osteogenic sarcoma.
Cancer chemotherapy and pharmacology 1994;33(5):420-4.
1994: Jacques Catalin; A F Peloux; F Coloma; B Payet; Bruno Lacarelle; J P Cano; S Just-Landi
Direct determination of mitoxantrone in plasma by high performance liquid chromatography using an automatic precolumn-switching system as sample clean-up procedure.
Biomedical chromatography : BMC 1994;8(1):37-41.
1994: Bruno Lacarelle; Olivier Blin; C Audebert; P Auquier; H Karsenty; F Horriere; A Durand
The quinolone, flumequine, has no effect on theophylline pharmacokinetics.
European journal of clinical pharmacology 1994;46(5):477-8.
1993: J F Rajaonarison; Bruno Lacarelle; Jacques Catalin; Alain Durand; J P Cano
Effect of anticancer drugs on the glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes.
Drug metabolism and disposition: the biological fate of chemicals 1993;21(5):823-9.
1993: J F Rajaonarison; Bruno Lacarelle; Alain Durand; Jacques Catalin
[In vitro metabolism of zidovudine in man].
Thérapie 1993;48(4):341-3.
1993: Bruno Lacarelle; J F Rajaonarison; Jacques Catalin; Alain Durand; J P Cano
UDP-glucuronosyltransferase activity toward digitoxigenin monodigitoxoside in human liver microsomes.
Drug metabolism and disposition: the biological fate of chemicals 1993;21(2):338-41.
1993: C Le Guellec; Bruno Lacarelle; Jacques Catalin; Alain Durand
Inhibitory effects of anticancer drugs on dextromethorphan-O-demethylase activity in human liver microsomes.
Cancer chemotherapy and pharmacology 1993;32(6):491-5.
1992: René Bruno; M C Iliadis; Bruno Lacarelle; V Cosson; J W Mandema; Y Le Roux; Guy Montay; A Durand; M Ballereau; M Alasia
Evaluation of Bayesian estimation in comparison to NONMEM for population pharmacokinetic data analysis: application to pefloxacin in intensive care unit patients.
Journal of pharmacokinetics and biopharmaceutics 1992;20(6):653-69.
1992: M Dou; Georges de Sousa; Bruno Lacarelle; M Placidi; P Lechene de la Porte; M Domingo; H Lafont; Roger Rahmani
Thawed human hepatocytes in primary culture.
Cryobiology 1992;29(4):454-69.
1992: J F Rajaonarison; Bruno Lacarelle; Jacques Catalin; M Placidi; Roger Rahmani
3'-azido-3'-deoxythymidine drug interactions. Screening for inhibitors in human liver microsomes.
Drug metabolism and disposition: the biological fate of chemicals 1992;20(4):578-84.
1992: F Marre; Gérard Fabre; Bruno Lacarelle; M Bourrie; Jacques Catalin; Y Berger; Roger Rahmani; J P Cano
Involvement of the cytochrome P-450IID subfamily in minaprine 4-hydroxylation by human hepatic microsomes.
Drug metabolism and disposition: the biological fate of chemicals 1992;20(2):316-21.
1991: J F Rajaonarison; Bruno Lacarelle; Georges de Sousa; Jacques Catalin; Roger Rahmani
In vitro glucuronidation of 3'-azido-3'-deoxythymidine by human liver. Role of UDP-glucuronosyltransferase 2 form.
Drug metabolism and disposition: the biological fate of chemicals 1991;19(4):809-15.
1991: Bruno Lacarelle; F Marre; Alain Durand; H Davi; Roger Rahmani
Metabolism of minaprine in human and animal hepatocytes and liver microsomes--prediction of metabolism in vivo.
Xenobiotica; the fate of foreign compounds in biological systems 1991;21(3):317-29.
1991: Bruno Lacarelle; J F Rajaonarison; T Gauthier; M Placidi; Jacques Catalin; Roger Rahmani
Use of a human liver microsome bank in drug glucuronidation studies.
Toxicology in vitro : an international journal published in association with BIBRA 1991;5(5-6):559-62.
1991: G de Sousa; M Dou; D Barbe; Bruno Lacarelle; M Placidi; Roger Rahmani
Freshly isolated or cryopreserved human hepatocytes in primary culture: Influence of drug metabolism on hepatotoxicity.
Toxicology in vitro : an international journal published in association with BIBRA 1991;5(5-6):483-6.
1991: Bruno Lacarelle; F Marre; T Blanc-Gauthier; X J Zhou; M Placidi; Jacques Catalin; Roger Rahmani
Use of human and animal liver microsomes in drug metabolic studies.
European journal of drug metabolism and pharmacokinetics 1991;Spec No 3():458-65.
1991: Bruno Lacarelle; Roger Rahmani; Georges de Sousa; A Durand; M Placidi; J P Cano
Metabolism of digoxin, digoxigenin digitoxosides and digoxigenin in human hepatocytes and liver microsomes.
Fundamental & clinical pharmacology 1991;5(7):567-82.
1990: J Albanese; Claude Martin; Bruno Lacarelle; P Saux; A Durand; F Gouin
Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients.
Anesthesiology 1990;73(2):214-7.
1987: P Crevat-Pisano; C Drouet; Bruno Lacarelle; M Alazia; G Francois; J P Cano
Validation of a radioreceptor assay technique for monitoring pharmacological active material during intensive diazepam tetanus therapy.
International journal of clinical pharmacology, therapy, and toxicology 1987;25(7):366-73.
1987: Bruno Lacarelle; C Granthil; J C Manelli; Nicolas Bruder; G Francois; J P Cano
Evaluation of a Bayesian method of amikacin dosing in intensive care unit patients with normal or impaired renal function.
Therapeutic drug monitoring 1987;9(2):154-60.